Home   Business   Life Science

Subscribe Now

Life Science




Precision medicine combination to be offered to more ovarian cancer patients

Precision medicine combination to be offered to more ovarian cancer patients

Precision medicine combination to be offered to more ovarian cancer patients

Olaparib - discovered by Prof Steve Jackson’s team at the University of Cambridge - is available with bevacizumab under the Cancer Drugs Fund.


Cambridge Consultants develops core technology for Ellume’s world-first fully-at-home over-the-counter Covid-19 test

Cambridge Consultants develops core technology for Ellume’s world-first fully-at-home over-the-counter Covid-19 test

Cambridge Consultants develops core technology for Ellume’s world-first fully-at-home over-the-counter Covid-19 test

The US government has struck a $231.8m deal for the delivery of 8.5 million tests.


Abcam reports revenue growth in spite of restrictions facing half the world’s labs

Abcam reports revenue growth in spite of restrictions facing half the world’s labs

Abcam reports revenue growth in spite of restrictions facing half the world’s labs

The Cambridge-based life science research tools provider said demand has yet to return to normal.


Demand for lab space in Cambridge region at five-year high, says Bidwells

Demand for lab space in Cambridge region at five-year high, says Bidwells

Demand for lab space in Cambridge region at five-year high, says Bidwells

Its report says take-up of office and lab space returned to trend levels in the second half of 2020.

1

Cambridge Festival launches programme of events

Cambridge Festival launches programme of events

Cambridge Festival launches programme of events

The lineup for the inaugural online Cambridge Festival has gone live.


Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge

Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge

Illumina Accelerator Cambridge announces four chosen genomics start-ups and £20m match-funding pledge

They will get seed funding, access to facilities and lab space.


AstraZeneca posts stellar full-year results for 2020 powered by new medicines

AstraZeneca posts stellar full-year results for 2020 powered by new medicines

AstraZeneca posts stellar full-year results for 2020 powered by new medicines

Revenues rose 10 per cent to $26.62billion.


Cambridge company supports trial to keep over-65s with Covid-19 out of hospital

Cambridge company supports trial to keep over-65s with Covid-19 out of hospital

Cambridge company supports trial to keep over-65s with Covid-19 out of hospital

ReCoVa-19 is aiding recruitment through its testing programme.


Blood test for minimal residual disease in cancer patients will be accelerated by $35m Inivata financing

Blood test for minimal residual disease in cancer patients will be accelerated by $35m Inivata financing

Blood test for minimal residual disease in cancer patients will be accelerated by $35m Inivata financing

It raises Series C financing to $60m


Sano Genetics to accelerate long Covid research after £2.5m seed funding

Sano Genetics to accelerate long Covid research after £2.5m seed funding

Sano Genetics to accelerate long Covid research after £2.5m seed funding

The Cambridge-based digital health technology company will supply at-home DNA testing kits for 3,000 patients.

1

Astex and Taiho strike further oncology licensing deal with MSD

Astex and Taiho strike further oncology licensing deal with MSD

Astex and Taiho strike further oncology licensing deal with MSD

It focuses on small molecule SHP2 inhibitor candidates.


Sanofi to acquire Babraham Research Campus-based Kymab in deal worth up to $1.45bn

Sanofi to acquire Babraham Research Campus-based Kymab in deal worth up to $1.45bn

Sanofi to acquire Babraham Research Campus-based Kymab in deal worth up to $1.45bn

The deal is expected to be completed in the first half of 2021.


Light Blue Fibre’s full-fibre network enables high-performance computing in Cambridge region

Light Blue Fibre’s full-fibre network enables high-performance computing in Cambridge region

Light Blue Fibre’s full-fibre network enables high-performance computing in Cambridge region

It is designed to handle the massive data demands for the life science industry and explosion in artificial intelligence.


Sosei Heptares to regain rights from AbbVie to programmes targeting neurological diseases

Sosei Heptares to regain rights from AbbVie to programmes targeting neurological diseases

Sosei Heptares to regain rights from AbbVie to programmes targeting neurological diseases

They were initially licensed to Allergan.


This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies - Learn More